Connection

Brett Froeliger to Smoking Cessation

This is a "connection" page, showing publications Brett Froeliger has written about Smoking Cessation.
Connection Strength

2.159
  1. Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability. JAMA Psychiatry. 2017 04 01; 74(4):379-386.
    View in: PubMed
    Score: 0.306
  2. Depressive symptoms and responses to cigarette pack warning labels among Mexican smokers. Health Psychol. 2016 May; 35(5):442-53.
    View in: PubMed
    Score: 0.283
  3. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242.
    View in: PubMed
    Score: 0.275
  4. Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. Psychopharmacology (Berl). 2010 Jul; 210(4):577-83.
    View in: PubMed
    Score: 0.189
  5. Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. Nicotine Tob Res. 2007 Mar; 9(3):351-63.
    View in: PubMed
    Score: 0.152
  6. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation. Drug Alcohol Depend. 2022 Oct 01; 239:109596.
    View in: PubMed
    Score: 0.111
  7. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review. Nicotine Tob Res. 2022 03 26; 24(5):633-642.
    View in: PubMed
    Score: 0.108
  8. Assessing combined effects of varenicline and N-acetylcysteine on reducing nicotine seeking in rats. Addict Biol. 2022 03; 27(2):e13151.
    View in: PubMed
    Score: 0.107
  9. A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation. Nicotine Tob Res. 2021 05 24; 23(6):983-991.
    View in: PubMed
    Score: 0.102
  10. Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
    View in: PubMed
    Score: 0.086
  11. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.080
  12. Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Mar 01; 74(3):214-223.
    View in: PubMed
    Score: 0.076
  13. A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
    View in: PubMed
    Score: 0.073
  14. The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. Addict Biol. 2016 07; 21(4):954-61.
    View in: PubMed
    Score: 0.067
  15. Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. Neuropsychopharmacology. 2014 Nov; 39(12):2750-9.
    View in: PubMed
    Score: 0.063
  16. Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. Addict Biol. 2010 Oct; 15(4):480-90.
    View in: PubMed
    Score: 0.049
  17. Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes. Neuropsychopharmacology. 2015 Oct; 40(11):2648-56.
    View in: PubMed
    Score: 0.017
  18. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.